Middle East and Africa Infection Control Market, By Product (Sterilization, Cleaning and Disinfection, Personal Protective Barriers, Endoscope Reprocessing, Anti-Microbial Surfaces, Other Infection Control), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others) – Industry Trends and Forecast to 2030.
Middle East and Africa Infection Control Market Analysis and Size
The market is primarily driven by an increase in surgical procedures that necessitate high-intensity infection prevention. The high preference is due to positive clinical outcomes associated with infection control use. The COVID-19 pandemic has boosted market growth by increasing demand for sterilization and disinfection in hospitals and clinics, pharmaceutical and medical device companies.
Data Bridge Market Research analyses that the infection control market which is USD 404.73 million in 2022, is expected to reach USD 830.43 million by 2030, at a CAGR of 9.4% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Infection Control Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Sterilization, Cleaning and Disinfection, Personal Protective Barriers, Endoscope Reprocessing, Anti-Microbial Surfaces, Other Infection Control), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others)
|
|
Countries Covered
|
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
|
|
Market Players Covered
|
STERIS plc (U.S.), Sotera Health Company (U.S.), Getinge AB (Sweden), Advanced Sterilization Products (ASP) (U.S.), Ecolab Inc. (U.S.), 3M (U.S.), MATACHANA GROUP (Spain), MMM Group (Germany), Belimed AG (Switzerland), Reckitt Benckiser (U.K.), Metrex Research LLC (U.K.), Miele Group (Germany), Pal International (U.K.), MELAG Medizintechnik GmbH & Co. KG (Germany), Contec, Inc. (U.S.), MEDALKAN (Greece), Systec GmbH (Germany), C.B.M. S.r.l. Medical Equipment (Italy), Continental Equipment Company (U.S.), and BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
|
|
Market Opportunities
|
|
Market Definition
Infection control in healthcare settings prevents or slows the spread of infections. Infection control refers to the policies and procedures implemented in hospitals and other healthcare settings to control and minimize the spread of infections with the primary goal of lowering infection rates.
Middle East and Africa Infection Control Market Dynamics
Drivers
- Rising involvement of government organizations
In the forecast period, the market is expected to develop as a result of the rising involvement of governmental organizations in the publication of recommendations to spread knowledge about practical preventative strategies. For instance, the World Health Organization (WHO) has issued guidelines in healthcare for the prevention and control of pandemic and epidemic-prone acute respiratory diseases. The guidelines cover everything from standard precautions like hand hygiene and the use of personal protective equipment to disinfection and sterilization procedures.
- Increase in hospitalization duration with surgical infections
According to a WHO guidelines on HAI prevention, the increase in hospitalization duration with surgical infections was found to be approximately 8 days. These extended stays are expected to contribute significantly to the overall costs incurred during the hospitalization, raising the clinical urgency for infection prevention measures to be implemented.
Furthermore, according to data from the National Nosocomial Infection Surveillance (NNIS) system report, catheterization is the most common cause of hospital-acquired UTIs, and CA-bacteriuria is the most common HAI worldwide, accounting for up to 40% of HAIs in the United States each year. These elements should increase the market's potential for future expansion.
Opportunities
- Increasing use of E-beam sterilization
Beta radiation, often known as electron-beam irradiation, is frequently used to sterilize medical equipment and pharmaceutical packaging. It works by continuously passing electrons through the items being sterilized. The benefit of this treatment is that it offers quick-turn terminal sterilization using straightforward, hygienic on/off technology. The product can be distributed immediately because no residuals or radioactive or carcinogenic gas sources are required. The market for infection control is anticipated to have considerable expansion during the forecast period as a result of the expanding applications of e-beam sterilization and its adoption among various end-user sectors.
Restraints/Challenges
- Concerns about the safety of the processed instruments
Concerns about the safety of the processed instruments used in surgeries are extremely dangerous for patients as well as healthcare workers or professionals, resulting in the spread of infection and acting as a restraint factor hampered the growth of the infection control market.
This infection control market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infection control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2020, Getinge AB launched superfast indicators to further ensure patient safety. The new Superfast 20 indicators are ISO 11138 compliant and compatible with most steam and hydrogen peroxide process sterilizers. This product launch will assist the company in increasing its market share in the infection control market.
- In 2019, Cardinal Health announced the acquisition of mscripts, a company that provides patient adherence and engagement solutions through an innovative, user-friendly mobile and web-based health management platform. This will assist the company in promoting patient adherence to prescriptions and improving overall health outcomes.
Middle East and Africa Infection Control Market Scope
The infection control market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Sterilization
- Cleaning and Disinfection
- Personal Protective Barriers
- Endoscope Reprocessing
- Anti-Microbial Surfaces
- Other Infection Control
Application
- Surgical Instruments
- Endoscopes
- Ultrasound Probes
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Third Party Distributors
End User
- Hospitals
- Clinics
- Medical Device Companies
- Pharmaceutical and Biotechnology Companies
- Laboratories
- Others
Infection Control Market Regional Analysis/Insights
The infection control market is analyzed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.
The countries covered in the infection control market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
South Africa is expected to grow in the forecast period of 2023 to 2030 as the country grows, so does the number of companies, R&D capabilities and demand for infection control products.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The infection control market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infection control market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infection control market. The data is available for historic period 2011-2021.
Competitive Landscape and Infection Control Market Share Analysis
The infection control market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infection control market.
Some of the major players operating in the infection control market are:
- STERIS plc (U.S.)
- Sotera Health Company (U.S.)
- Getinge AB (Sweden)
- Advanced Sterilization Products (ASP) (U.S.)
- Ecolab Inc. (U.S.)
- 3M (U.S.)
- MATACHANA GROUP (Spain)
- MMM Group (Germany)
- Belimed AG (Switzerland)
- Reckitt Benckiser (U.K.)
- Metrex Research LLC (U.K.)
- Miele Group (Germany)
- Pal International (U.K.)
- MELAG Medizintechnik GmbH & Co. KG (Germany)
- Contec, Inc. (U.S.)
- MEDALKAN (Greece)
- Systec GmbH (Germany)
- C.B.M. S.r.l. Medical Equipment (Italy)
- Continental Equipment Company (U.S.)
- BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
SKU-